PIII · NASDAQ · Medical - Care Facilities

P3 Health Partners (PIII)

Runs at-risk Medicare Advantage arrangements through local primary-care-provider networks.

$7.78
vs last close+0.18 (+2.37%)
Loading prices…

P3 Health Partners Inc.PIII
Health Care

Runs at-risk Medicare Advantage population-health arrangements through local primary-care-provider networks in five U.S. states. Its model combines physician leadership, data and technology, care coordination, and community outreach; the Nasdaq-listed parent is the sole manager of P3 LLC, which holds substantially all operations.

Runs at-risk population-health-management arrangements for insurance plans serving Medicare Advantage beneficiaries. Local primary-care-provider networks execute care coordination and administrative support, while physician leadership, data and technology, and community outreach underpin the model.

Commercial operations began in 2017, and P3 works across five U.S. states. It supports patients, providers, and caregivers with a care model designed to improve outcomes and lower care costs.

The public company was formed through a 2021 combination with Foresight Acquisition Corp. It is the sole manager of P3 LLC, which holds substantially all operating assets and operations.

Company facts

CEOAric Coffman, M.D.
ListedDec 6, 2021
ExchangeNASDAQ
HeadquartersHenderson, NV
CountryUnited States
Employees320
CIK0001832511
ISINUS7444132044

Market cap$24.9M
EPS (ttm)−$32.95
P/E (ttm)−0.2307
ROE
P/B0.3449
P/S0.0166
Dividend yieldDiv yield
Beta−1.49vs XLV −0.11

Price target$18.50+143.4%Average of 4 analysts
ConsensusBuy2 of 4 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Aug 11, 2026Lake StreetReiterate
Rating: Target: $4
Rating: BuyTarget: $23
May 15, 2026UBSTarget
Target:
Target: $14
Mar 27, 2026Lake StreetReiterate
Rating: Target: $12.50
Rating: BuyTarget: $4
Nov 17, 2025Lake StreetReiterate
Rating: Target: $20
Rating: BuyTarget: $12.50

Next report
Nov 12, 26
in 51 days
EPS estimate
−$3.97
Revenue estimate
$385.2M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$16.00−$6.28−$6.23−$9.67−$23.02$0.32−$0.63Pending
Estimate−$8.50−$5.00−$3.29−$5.29−$8.06−$4.85−$1.89−$3.97
Surprise−88.2%−25.6%−89.4%−82.7%−185.5%+106.6%+66.7%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$370.7M$373.2M$355.8M$345.3M$384.8M$386.4M$386.4MPending
Estimate$378.9M$349.8M$344.9M$346.6M$353.7M$391.5M$377.8M$385.2M
Surprise−2.2%+6.7%+3.2%−0.4%+8.8%−1.3%+2.3%
Estimate−$3.97
ReportedDue Nov 12, 2026
Estimate$385.2M
ReportedDue Nov 12, 2026
View details

Debt to equity180.50%
Current ratio46.20%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$362.1M$370.7M$373.2M$355.8M$345.3M$384.8M$386.4M$386.4M
Net income−$46.5M−$58.6M−$20.5M−$20.4M−$31.6M−$75.5M$1.2M$7.4M
Net margin0.0%0.0%0.0%0.0%0.0%0.0%0.3%1.9%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income−$107.0M−$130.4M−$38.1M−$34.1M−$44.2M−$153.9M$8.2M$41.2M
YoY growthLoss widenedLoss widenedLoss narrowedLoss widenedLoss narrowedLoss widenedTurned profitTurned profit

Balance sheet, Jun 30, 2026Cash & short-term investments $21.3M · Total debt $130.3M · Total assets $654.4M · Shareholders' equity $72.2M

Revenue
$386.4M
Operating income
$41.2M
Net income
$7.4M
View details

No dividends on record.

Institutions3.98%288.9K shares
19 holders · as of Jun 30, 2026
Insiders0.44%31.7K shares
4 holders · as of Jan 23, 2026
Strategic holders11.43%829.7K shares
1 holder · as of Aug 14, 2026
Other84.15%6.11M shares
remainder

7.26M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Two share counts disagree (7.26M in the company's Sep 22, 2026 report, 3.28M elsewhere); stakes use the report.

This company has 2 share classes; every stake here is a share of the whole company.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Hudson Vegas Investment SPV, LLCStrategic10 percent owner
11.43%100,000 A · 729,651 Vfiled Aug 14, 2026
HRT Financial LPInstitution
0.75%54,717 Aas of Jun 30, 2026
Jane Street Group, LLCInstitution
0.75%54,495 Aas of Jun 30, 2026
Vanguard Capital Management LLCInstitution
0.57%41,484 Aas of Jun 30, 2026
Myda Advisors LLCInstitution
0.28%20,000 Aas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Aug 10, 2026Hudson Vegas Investment SPV, LLC10 percent owner−50,000$16.48
View details

  • Agilon Health

    Full-risk physician partner for Medicare Advantage seniors

  • Astrana Health

    Risk-bearing, technology-enabled physician-network management

  • CVS Health

    Oak Street Health runs value-based primary care for Medicare patients

Compare

CompanyPriceChange
P3 Health Partners$7.78+2.37%$24.9M0.0+8.6%
Agilon Health$88.37+0.39%$1.47B0.2+7.2%
Astrana Health$35.36+5.39%$1.66B41.021.40.4+48.5%
CVS Health$87.26−0.39%$111.77B23.210.80.3+7.3%
Median32.116.10.3+7.3%